
Patients with chronic lymphocytic leukemia (CLL) often face months or years of uncertainty. A new study might help those patients better understand their progression timeline.

Patients with chronic lymphocytic leukemia (CLL) often face months or years of uncertainty. A new study might help those patients better understand their progression timeline.

A new rule makes it impossible for patients with end-stage renal disease (ESRD) to take part in Medicare Advantage, leaving them out of coordinated care.

Certain aspects of satisfaction with multiple sclerosis (MS) treatment can impact health-related quality of life (HRQOL).

The thalamus is among the first brain areas to atrophy in multiple sclerosis (MS); this study wanted to know if measuring this loss can predict future disability.

Patients with connective tissue diseases are at greater risk for severe coronavirus disease 2019 (COVID-19) than patients with chronic inflammatory arthritis.

A recent study explored how chronic pain affects occupational status, the distribution of household chores, and marital satisfaction.

DA-9701 therapy was found to improve the severity of gastrointestinal symptom–related quality of life and severity in patients with Parkinson disease, with no adverse effects on motor symptoms, according to study findings.

Screening women aged 40 to 49 years for breast cancer reduced mortality by 25% in the first 10 years compared with waiting until at age 50 years and older, which is the common practice in the United Kingdom.

The risk of orthopedic surgery has declined for patients with rheumatoid arthritis (RA) over the course of decades, but the same trend has not occurred for patients with psoriatic arthritis.

A significant proportion of patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) experience bleeding when taking ibrutinib—a recent study probes why.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

New data from the CDC show startling declines in mental health; Biden recommends public mask-wearing for 3 months; FDA issues new warning on hand sanitizers.

This week in managed care, the top news included all-cause mortality disparities among Black and White men in rural areas; vaping as a risk factor for COVID-19 in young adults; how the pandemic presents an opportunity for value-based care delivery.

Most oncologists in a recent survey said they lack the knowledge and data to use measurable, or minimal, residual disease (MRD) as a decision-making tool in the treatment of multiple myeloma.

In a webinar, experts outlined challenges providers face amid the coronavirus disease 2019 (COVID-19) pandemic and the benefits of increased access to high-value care during the outbreak and beyond.

High-quality research is needed to generate evidence to back neurofeedback for pain management, a recent review says.

Short-term use of acetazolamide was shown to improve both obstructive sleep apnea (OSA) and central sleep apnea (CSA), with significantly greater reductions in the apnea-hypopnea index observed with higher doses.

HIV-specific antibodies of 3 immunoglobulin isotypes are readily found in human saliva, providing a potential second reliable method of detecting the virus that may be used as a painless alternative to a blood draw.

As the American Society of Clinical Oncology calls for more aggressive efforts to bring equity to cancer care, authors in JAMA Oncology say COVID-19 is creating wider gaps.

Thousands have been told to quarantine after outbreaks in schools; children are missing scheduled vaccines; CDC's Robert Redfield, MD, warns of the worst fall in US public health history.

A study in Annals of Internal Medicine shows severe obesity presents a greater risk of death from COVID-19 than related factors such as diabetes or hypertension.

To reduce poor outcomes from heart failure care disparities, Danish researchers probed the link between individual socioeconomic factors and care quality for patients with reduced ejection fraction.

Most studies have evaluated PsA-associated fatigue in western populations. A new study has highlighted that PsA-associated fatigue is also prevalent in an Asian population and correlates with disease activity, impact, and chronicity.

Given the constraints prevalent post-COVID-19, Dr Mark Fendrick, director of the University of Michigan Center for Value-Based Insurance Design, stresses that it is now more important than ever for the health care industry to prioritize payment reform, value-based benefit design, and novel policy initiatives.

In individuals with type 1 diabetes (T1D), bacterial infections are associated with an increased risk of coronary heart disease, according to a study published in the Journal of Internal Medicine.

It is the first such approval for a diagnostic that combines next-generation sequencing and liquid biopsy in one test.

Retinal venular widening and a higher vessel tortuosity are associated with lower performance of short-term visual recognition memory in children aged 4 to 5 years, according to a study published in JAMA Network Open.

Moderna will receive over $1.5 billion for 100 million doses of its coronavirus disease 2019 (COVID-19) vaccine candidate; researchers isolated COVID-19 from the air; New Zealand had no new cases of COVID-19 for almost 4 months.

A Marshall University researcher received $444,000 from NIH to continue researching a new treatment target in chronic renal failure.

A real-world study showed that ruxolitinib is a safe treatment for patients with myelofibrosis.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
